Hrt Financial LP Vaxxinity, Inc. Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$1.43 - $4.24 $99,120 - $293,895	69,315 New	69,315 $157,000
Q2 2022 Aug 12, 2022	SELL	$1.55 - $6.95 $26,489 - $118,775	-17,090 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.7 - $8.6 $125,518 - $291,746	-33,924 Reduced 66.5%	17,090 $73,000
Q4 2021 Feb 14, 2022	BUY	$5.55 - $18.46 $283,127 - $941,718	51,014 New	51,014 $286,000

198K

Ticker VAXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 112,150,000
Description
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.